A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors

MLA

B. Fallon, et al. “A Phase I Study of an Outpatient Regimen of Recombinant Human Interleukin-2 and Alpha-2a-Interferon in Patients with Solid Tumors.” Cancer, vol. 68, Oct. 1991, pp. 1708–13. EBSCOhost, https://doi.org/10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co;2-v.

APA

B. Fallon, Harriet A. Bering, J. Tessitore, Jerome E. Groopman, Mark S. Huberman, D. Levitt, Paul S, H. Sonnenborn, & J. Zeffren. (1991). A phase I study of an outpatient regimen of recombinant human interleukin-2 and alpha-2a-interferon in patients with solid tumors. Cancer, 68, 1708–1713. https://doi.org/10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co;2-v

Chicago

B. Fallon, Harriet A. Bering, J. Tessitore, Jerome E. Groopman, Mark S. Huberman, D. Levitt, Paul S, H. Sonnenborn, and J. Zeffren. 1991. “A Phase I Study of an Outpatient Regimen of Recombinant Human Interleukin-2 and Alpha-2a-Interferon in Patients with Solid Tumors.” Cancer 68 (October): 1708–13. doi:10.1002/1097-0142(19911015)68:8<1708::aid-cncr2820680810>3.0.co;2-v.